HANXBIO-B (03378) announced its interim results, reporting a loss attributable to shareholders of 36.883 million yuan, an increase of 1.22% year-on-year.
Hans Resource Energy-B (03378) announced its interim results for the period ending June 30, 2026. The group's other income and gains amounted to 27.614 million yuan (RMB, same below), a year-on-year increase of 421.02%; the loss attributable to equity holders of the parent company was 36.883 million yuan, an increase of 1.22% year-on-year; and the basic and diluted loss per share was 0.27 cents.
HANXBIO-B (03378) announced its interim results for the period ending June 30, 2026, reporting other income and gains of 27.614 million yuan (RMB, the same below), an increase of 421.02% year-on-year; loss attributable to owners of the parent company was 36.883 million yuan, a year-on-year increase of 1.22%; basic and diluted loss per share was 0.27 cents.
The announcement stated that the increase in other income and gains was mainly due to the increased fair value gains from the variable consideration generated by the sale of an associated company.
Related Articles
STAR SPORTS MED (01609): Obtained EU MDR certification and multiple overseas market product registration approvals.
BOC AVIATION (02588) has entered into an agreement for the purchase and long-term lease of 12 Airbus A320NEO aircraft.
LIFETECH SCI (01302): The LantvalTM Aortic Valve Replacement System has entered the Innovative Medical Management device special review process.
STAR SPORTS MED (01609): Obtained EU MDR certification and multiple overseas market product registration approvals.
BOC AVIATION (02588) has entered into an agreement for the purchase and long-term lease of 12 Airbus A320NEO aircraft.
LIFETECH SCI (01302): The LantvalTM Aortic Valve Replacement System has entered the Innovative Medical Management device special review process.
RECOMMEND
